You just read:

Eventus Diagnostics Completes $2.72 Million Financing To Support Commercialization Of Its Octava™ Blood Tests For Breast Cancer Detection

News provided by

Eventus Diagnostics, Inc.

Apr 15, 2014, 07:30 ET